Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: an update on current advances and …
Neurodegenerative diseases (NDs) such as Alzheimer disease (AD), Parkinson disease
(PD), and Huntington disease (HD) represent a major socio-economic challenge in view of …
(PD), and Huntington disease (HD) represent a major socio-economic challenge in view of …
Mitochondrial dysfunction in Parkinson's disease–a key disease hallmark with therapeutic potential
MT Henrich, WH Oertel, DJ Surmeier… - Molecular …, 2023 - Springer
Mitochondrial dysfunction is strongly implicated in the etiology of idiopathic and genetic
Parkinson's disease (PD). However, strategies aimed at ameliorating mitochondrial …
Parkinson's disease (PD). However, strategies aimed at ameliorating mitochondrial …
Parkinson's disease kinase LRRK2 coordinates a cell-intrinsic itaconate-dependent defence pathway against intracellular Salmonella
Cell-intrinsic defences constitute the first line of defence against intracellular pathogens. The
guanosine triphosphatase RAB32 orchestrates one such defence response against the …
guanosine triphosphatase RAB32 orchestrates one such defence response against the …
Trichloroethylene: An invisible cause of Parkinson's disease?
The etiologies of Parkinson's disease (PD) remain unclear. Some, such as certain genetic
mutations and head trauma, are widely known or easily identified. However, these causes or …
mutations and head trauma, are widely known or easily identified. However, these causes or …
Leucine-Rich Repeat Kinases
DR Alessi, SR Pfeffer - Annual Review of Biochemistry, 2024 - annualreviews.org
Activating mutations in leucine-rich repeat kinase 2 (LRRK2) represent the most common
cause of monogenic Parkinson's disease. LRRK2 is a large multidomain protein kinase that …
cause of monogenic Parkinson's disease. LRRK2 is a large multidomain protein kinase that …
Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives
J Hu, D Zhang, K Tian, C Ren, H Li, C Lin… - European Journal of …, 2023 - Elsevier
Leucine-rich repeat kinase 2 (LRRK2) is a multifunctional protein that orchestrates a diverse
array of cellular processes, including vesicle transport, autophagy, lysosome degradation …
array of cellular processes, including vesicle transport, autophagy, lysosome degradation …
LRRK2 suppresses lysosome degradative activity in macrophages and microglia through MiT-TFE transcription factor inhibition
N Yadavalli, SM Ferguson - Proceedings of the National …, 2023 - National Acad Sciences
Cells maintain optimal levels of lysosome degradative activity to protect against pathogens,
clear waste, and generate nutrients. Here, we show that LRRK2, a protein that is tightly …
clear waste, and generate nutrients. Here, we show that LRRK2, a protein that is tightly …
The role of microglial LRRK2 kinase in manganese-induced inflammatory neurotoxicity via NLRP3 inflammasome and RAB10-mediated autophagy dysfunction
E Pajarillo, S Kim, A Digman, M Dutton, DS Son… - Journal of Biological …, 2023 - ASBMB
Chronic manganese (Mn) exposure can lead to manganism, a neurological disorder sharing
common symptoms with Parkinson's disease (PD). Studies have shown that Mn can …
common symptoms with Parkinson's disease (PD). Studies have shown that Mn can …
[HTML][HTML] Healthy human fecal microbiota transplantation into mice attenuates MPTP-induced neurotoxicity via AMPK/SOD2 pathway
Increasing evidence has shown that gut dysbacteriosis may play a crucial role in
neuroinflammation in Parkinson's disease (PD). However, the specific mechanisms that link …
neuroinflammation in Parkinson's disease (PD). However, the specific mechanisms that link …
The body, the brain, the environment, and Parkinson's disease
ER Dorsey, BR De Miranda… - Journal of …, 2024 - journals.sagepub.com
The brain-and body-first models of Lewy body disorders predict that aggregated alpha-
synuclein pathology usually begins in either the olfactory system or the enteric nervous …
synuclein pathology usually begins in either the olfactory system or the enteric nervous …